“Reporting Information Regarding Falsification of Data” Proposed Rule

First Page		Document Content
Pharmacokinetics Drug discovery Pharmaceutical industry Clinical research Clinical pharmacology Bioavailability Pre-clinical development Bioequivalence Drug development Pharmaceutical sciences Pharmacology Pharmaceutics		“Reporting Information Regarding Falsification of Data” Proposed Rule Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 420,28 KB Share Document on Facebook

	Collaborative Network Award Planning Grants – Project Summaries PRIORITY AREA: Projects that will drive development of one or more pre-clinical drug candidates through identification and validation of molecular and cel DocID: 1tiAJ - View Document
	27 JANUARY 2016 BIOSIMILARS DEVELOPMENT - FROM PRE-CLINIC TO MARKET Several biological products, altogether worth over US$60 billion annual sales, are encountering patent expiry byThis opens up the opportunity for DocID: 1rnQJ - View Document
	New NIH guidelines to improve Experimental Rigor and Reproducibility Oswald Steward Professor, Department of Anatomy & Neurobiology Senior Associate Dean for Research University of California School of Medicine DocID: 1rjyT - View Document
	Morris Animal Foundation The Osteosarcoma Project Proposal Guidelines General Information: Morris Animal Foundation (MAF) is dedicated to funding proposals that are relevant to our mission of advancing the health and wel DocID: 1rc22 - View Document
	CME Session 8 – Physics/Translational Molecular Imaging and Therapy October 17, 2016, 16:30 – 18:00 QA/QC Preclinical Systems and Preclinical Imaging Procedures DocID: 1qddF - View Document